Soft-shell clam (Mya arenaria) p53: A structural and functional comparison to human p53

Gene

Volumn 433, Issue 1-2, 2009, Pages 81-87

  Holbrook, Lauren A C ^a   Butler, Rondi A ^a   Cashon, Robert E ^a   Van Beneden, Rebecca J ^a  

^a UNIVERSITY OF MAINE   (United States)

Author keywords

Apoptosis; Bivalve; Cancer; Cell cycle arrest; Mdm2; Post translational modification

Indexed keywords

PROTEIN MDM2; PROTEIN P53;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CONTROLLED STUDY; ENZYME REGULATION; FEEDBACK SYSTEM; MYA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SPECIES DIFFERENCE;

ANIMALS; BIVALVIA; CELL LINE; FLOW CYTOMETRY; HUMANS; MODELS, MOLECULAR; RNA INTERFERENCE; SPECIES SPECIFICITY; TUMOR SUPPRESSOR PROTEIN P53;

BIVALVIA; INVERTEBRATA; MYA ARENARIA;

EID: 59649086886     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2008.11.029     Document Type: Article

References (40)

1. Agarwal M.L., Taylor W.R., Chernov M.V., Chernova O.B., and Stark G.R. The p53 network. J. Biol. Chem. 273 (1998) 1-4
2. Alarcon-Vargas D., and Ronai Z. p53-Mdm2 - the affair that never ends. Carcinogenesis 23 (2002) 541-547
3. Barber B.J. Neoplastic diseases of commercially important marine bivalves. Aquat. Living Resour. 17 (2004) 449-466
4. Barry M., and Yevich P.P. The ecological, chemical and histopathological evaluation of an oil spill site, part III: histopathological studies. Mar. Pollut. Bull. 6 (1975) 171-173
5. Bensaad K., and Vousden K.H. p53: new roles in metabolism. Trends Cell Biol. 17 (2007) 286-291
6. Böttger S.A., Jerszyk E.C., Low B.E., and Walker C.W. Genotoxic stress-induced expression of p53 and apoptosis in leukemic clam hemocytes with cytoplasmically sequestered p53. Cancer Res. 68 (2008) 777-782
7. Butler R.A., Kelley M.L., Gardner G.R., Olberding K.E., and Van Beneden R.J. Aryl hydrocarbon receptor (AHR)-independent effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on soft-shell clam (Mya arenaria) reproductive tissue. Comp. Biochem. Physiol. C 138 (2004) 375-381
8. Chehab N.H., Malikzay A., Stavridi E.S., and Halazonetis T.D. Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 13777-13782
9. Clore G.M., et al. Refined solution structure of the oligomerization domain of the tumour suppressor p53. Nat. Struct. Biol 2 (1995) 321-333
10. Curwen V., Eyras E., Andrews T.D., Clarke L., Mongin E., Searle S.M.J., and Clamp M. The Ensembl automatic gene annotation system. Genome Res. 14 (2004) 942-950
11. de Nooij J.C., and Hariharan I.K. Uncoupling cell fate determination from patterned cell division in the Drosophila eye. Science 270 (1995) 983-985
12. Derry W.B., Putzke A.P., and Rothman J.H. Caenorhabditis elegans p53: role in apoptosis, meiosis, and stress resistance. Science 294 (2001) 591-595
13. El-Deiry W.S., et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75 (1993) 817-825
14. Ho W.C., Fitzgerald M.X., and Marmorstein R. Structure of the p53 core domain dimer bound to DNA. J. Biol. Chem. 281 (2006) 20494-20502
15. Kannan K., Kaminski N., Rechavi G., Jakob-Hirsch J., Amariglio N., and Givol D. DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-1. Oncogene 20 (2001) 3449-3455
16. Kelley M.L., et al. Expression of homologues for p53 and p73 in the softshell clam (Mya arenaria), a naturally occurring model for human cancer. Oncogene 20 (2001) 748-758
17. Kraulis P.J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallography 24 (1991) 947-950
18. Kussie P.H., et al. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274 (1996) 948-953
19. Lavin M.F., and Gueven N. The complexity of p53 stabilization and activation. Cell Death Differ. 13 (2006) 941-950
20. Lin J., Chen J., Elenbaas B., and Levine A.J. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55kD protein. Genes Dev. 8 (1994) 1235-1246
21. Lu W.J., and Abrams J.M. Lessons from p53 in non-mammalian models. Cell Death Differ. 13 (2006) 909-912
22. McCoy M., Stravridi E.S., Waterman J.L.F., Wieczorek A.M., Opella S.J., and Halazonetis J.D. Hydrophobic side-chain size is a determinant of the three-dimensional structure of the p53 oligomerization domain. EMBO J. 16 (1997) 6230-6236
23. Michalak E., Villunger A., Erlacher M., and Strasser A. Death squads enlisted by tumour suppressor p53. Biochem. Biophys. Res. Commun. 331 (2005) 786-798
24. Moll U.M., and Petrenko O. The Mdm2-p53 interaction. Mol. Cancer Res. 1 (2003) 1001-1008
25. Ollmann M., et al. Drosophila p53 is a structural and functional homolog of the tumor suppressor p53. Cell 101 (2000) 91-101
26. Oren M. Decision making by p53: life, death and cancer. Cell Death Differ. 10 (2003) 431-442
27. Perry M.E. Mdm2 in the response to radiation. Mol. Cancer Res. 2 (2004) 9-19
28. Picksley S.M., Vojtesek B., Sparks A., and Lane D.P. Immunochemical analysis of the interaction of p53 with MDM2; fine mapping of the MDM2 binding site on p53 using synthetic peptides. Oncogene 9 (1994) 2523-2529
29. Sayle R., and Milner-White E.J. RasMol: biomolecular graphics for all. Trends Biochem. Sci. 20 (1995) 374
30. Shengkan J., and Levine A.J. The p53 functional circuit. J. Cell Sci. 114 (2001) 4139-4140
31. Sutcliffe J.E., Korenjak M., and Brehm A. Tumour suppressors - a fly's perspective. Eur. J. Cancer 39 (2003) 1355-1362
32. Suzuki M., Sunaga N., Shames D.S., Toyooka S., Gazdar A.F., and Minna J.D. RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells. Cancer Res. 64 (2004) 3137-3143
33. Sykes S.M., et al. Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol. Cell 24 (2006) 841-851
34. Unger T., et al. Critical role for Ser 20 of human p53 in the negative regulation of p53 by Mdm2. EMBO J. 18 (1999) 1805-1814
35. Unger T., et al. Mutations in serines 15 and 20 of human p53 impair its apoptotic activity. Oncogene 18 (1999) 3205-3212
36. Venot C., Maratrat M., Dureuil C., Conseiller E., Bracco L., and Debussche L. The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression. EMBO J. 17 (1998) 4668-4679
37. Vousden K.H. Activation of the p53 tumor suppressor protein. Biochim. Biophys. Acta 1602 (2002) 47-59
38. Vousden K.H., and Lane D.P. p53 in health and disease. Nat. Rev. Mol. Cell Biol. 8 (2007) 275-283
39. Walker C.W., and Böttger S.A. A naturally occurring cancer with molecular connectivity to human diseases. Cell Cycle 7 15 (2008) 2286-2289
40. Walker C., Böttger S., and Low B. Mortalin-based cytoplasmic sequestration of p53 in a non-mammalian cancer model. Amer. J. Pathol. 168 (2006) 1526-1530